:

Ronald P Taylor1, Margaret A Lindorfer1

  • 1Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia.

Current protocols
|October 13, 2023
PubMed
概括

抗体结合的目标被免疫细胞去除,阻碍了基于抗体的癌症疗法,如rituximab. 本研究详细介绍了分析和潜在地阻断该过程的方法,从而提高治疗效率.